Investment spotlight: Medivet

Key learnings covered in this topic

1. CareSuper invests in veterinary services provider, Medivet. 
2. Through our investment, your super is directly contributing to the enhancement of veterinary services and animal care
3. The investment is an example of our commitment to investing responsibly and sustainably. 

Founded in Watford, UK, Medivet has established itself as a fast-growing entity in veterinary services, operating over 500 clinics and a network of 24/7 veterinary hospitals spanning the UK, Spain, and Germany. The company is unique in its ‘Branch Partner’ co-ownership model, fostering a connected community of over 1,500 dedicated veterinarians committed to providing exceptional and consistent care.

In June 2023 a consortium of institutional partners led by LGT Capital Partners (LGT CP) made a significant growth investment in Medivet. This investment marks a major milestone in Medivet's journey, enhancing its presence and capabilities across the UK and internationally. In particular accelerating Medivet’s growth, bolstering its investment in people, technology, clinical facilities, and new clinic acquisitions. This infusion of funds and support from experienced partners is a testament to the progress Medivet has made and the trust placed in its vision and leadership.

So, what does this mean for CareSuper members?

By investing in Medivet, CareSuper is directly contributing to the enhancement of veterinary services and animal care. This aligns with our commitment to responsible and sustainable investments, ensuring that our members’ superannuation is not just growing, but also making a positive impact on communities and industries.

Interested in understanding how your super is making a difference? Dive into the world of Medivet and discover the ripple effect of your CareSuper investment in advancing veterinary care and services.

If you have questions or need advice about your CareSuper investments, feel free to contact us at 1300 360 149 or fill out our online contact form. We’re here to provide simple and general advice about your investment options and risk profile, all at no additional cost to you.
 

Information correct as at 28 November 2023.